2 completed, 1 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow eryaspase: new trials by email Literature Review of eryaspase trials Research Report on eryaspase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2) eryaspase (L-asparaginase encapsulated in red blood cells), Gemcitabine, Carboplatin - Triple Negative Breast Cancer | Phase 2 / Phase 3 | Terminated | ERYtech Pharma | 27 | 2019-06-13 | 2022-08-01 |
| Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase GRASPA - Acute Lymphoblastic Leukemia | Phase 2 | Completed | Birgitte Klug Albertsen | 55 | 2017-08-23 | 2024-03-15 |
| GRASPA Treatment for Patients With Acute Myeloblastic Leukemia GRASPA - Acute Myeloid Leukemia | Phase 2 | Completed | ERYtech Pharma | 123 | 2013-02-01 | 2022-02-21 |
Leukemia (1) · Leukemia, Myeloid, Acute (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Triple Negative Breast Neoplasms (1)
ERYtech Pharma (2) · Birgitte Klug Albertsen (1)
Belgium (1) · Denmark (1) · Estonia (1) · Finland (1) · France (1) · Hungary (1) · Lithuania (1) · Norway (1) · Spain (1) · Sweden (1)
Brigitte Klug Albertsen, MD, PhD (1) · X Thomas, Doctor (1)
2016 (1)